However, NBS1 may activate other pathways that promote EMT and metastasis since ~9% of metastatic head and neck cancer patient cases belonged to the NBS1(+)/Snail(-) group in our previous study [[17] and data not shown]. The gene discussed is SNAI1; the disease is head and neck cancer.